{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:05:56Z","timestamp":1784718356081,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajt.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:27:40Z","timestamp":1769128060000},"page":"1080-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Economic benefits of T cell-depleting induction in deceased donor kidney transplant recipients"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-0613","authenticated-orcid":false,"given":"David","family":"Axelrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-4849","authenticated-orcid":false,"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Preblick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Potukuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-5643","authenticated-orcid":false,"given":"Mark","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajt.2026.01.004_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13813","article-title":"Economic impacts of alternative kidney transplant immunosuppression: a national cohort study","volume":"34","author":"Axelrod","year":"2020","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/ajt.14702","article-title":"An economic assessment of contemporary kidney transplant practice","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/tri.12711","article-title":"Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice","volume":"29","author":"Naik","year":"2016","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.ajt.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.trre.2015.11.002","article-title":"A commercial transplant network\u2019s perspective of value in solid organ transplantation: strategizing for value in transplant care","volume":"30","author":"Irwin","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"issue":"suppl 2","key":"10.1016\/j.ajt.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/ajt.13672","article-title":"Economics","volume":"16","author":"Schnitzler","year":"2016","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1016\/j.ajt.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ajt.14018","article-title":"The changing financial landscape of renal transplant practice: a national cohort analysis","volume":"17","author":"Axelrod","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/tri.13079","article-title":"Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice","volume":"31","author":"Dharnidharka","year":"2018","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ajt.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.transproceed.2015.12.024","article-title":"Variation in comedication use according to kidney transplant immunosuppressive regimens: application of integrated registry and pharmacy claims data","volume":"48","author":"Lentine","year":"2016","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.ajt.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/ajt.13758","article-title":"National variation in use of immunosuppression for kidney transplantation: a call for evidence-based regimen selection","volume":"16","author":"Axelrod","year":"2016","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2026.01.004_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240929","article-title":"Induction therapy in kidney transplant recipients: description of the practices according to the calendar period from the French multicentric DIVAT cohort","volume":"15","author":"Boucquemont","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajt.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40472-021-00321-6","article-title":"Immunosuppression considerations for older kidney transplant recipients","volume":"8","author":"Cheungpasitporn","year":"2021","journal-title":"Curr Transplant Rep"},{"issue":"1","key":"10.1016\/j.ajt.2026.01.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2021.08.012","article-title":"Posttransplant diabetes mellitus and immunosuppression selection in older and obese kidney recipients","volume":"4","author":"Axelrod","year":"2022","journal-title":"Kidney Med"},{"issue":"2S1","key":"10.1016\/j.ajt.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.01.004_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14372","article-title":"A call for transplant stewardship: the need for expanded evidence-based evaluation of induction and biologic-based cost-saving strategies in kidney transplantation and beyond","volume":"35","author":"Jorgenson","year":"2021","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/TP.0000000000001310","article-title":"Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States","volume":"101","author":"Gharibi","year":"2017","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.01.004_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13257","article-title":"Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab","volume":"22","author":"Pham","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajt.2026.01.004_bib17","series-title":"2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2023"},{"issue":"20","key":"10.1016\/j.ajt.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ajt.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajt.2026.01.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103047","article-title":"Low-dose thymoglobulin versus basiliximab induction therapy in low-risk living related kidney transplant recipients: three-year follow-up study","volume":"55","author":"Martinez-Mier","year":"2024","journal-title":"Arch Med Res"},{"issue":"1","key":"10.1016\/j.ajt.2026.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2215536","article-title":"Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk - a retrospective analysis of UNOS database","volume":"55","author":"Ali","year":"2023","journal-title":"Ann Med"},{"issue":"11","key":"10.1016\/j.ajt.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/tri.12850","article-title":"Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study","volume":"29","author":"Dharnidharka","year":"2016","journal-title":"Transpl Int"},{"issue":"16","key":"10.1016\/j.ajt.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.3390\/jcm10163656","article-title":"Optimal immunosuppression strategy in the sensitized kidney transplant recipient","volume":"10","author":"Olaso","year":"2021","journal-title":"J Clin Med"},{"issue":"suppl 3","key":"10.1016\/j.ajt.2026.01.004_bib24","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:54:25Z","timestamp":1784717665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1600613526000067"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.01.004","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic benefits of T cell-depleting induction in deceased donor kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}